Research We Fund

SLICC is an international group dedicated to clinical research on lupus. In 2017, we began a collaboration with SLICC to study steroid damage at different doses. The goal of this project is to develop clinical guidelines for steroid dosing for lupus. Steroids are used frequently in the treatment of lupus, however, the side effects of higher doses of the medication can be significant.

Project Title: Glucocorticoid Dose and Exposure Time and Organ Damage in Patients with Systemic Lupus Erythematosus

Principal Investigator: Anselm Mak, MD, Medical University of Singapore

CARRA works to improve research aimed at finding the cause and cure for childhood rheumatic diseases. In 2017, the Lupus Foundation of America committed to a multi-year partnership to support CARRA. In the first year of the project, CARRA will develop a research agenda for childhood lupus that will ultimately aim to identify the top priorities needed in this field.

Project Title: Development of a Childhood Lupus Research Agenda

Principal Investigators: Aimee Hersh, MD, University of Utah; CARRA SLE Committee Chair
Andrea Knight, MD, MSCE, University of Toronto; CARRA SLE Committee Vice-Chair

More info

We are providing nearly $4 million to support a five-year, first-of-its-kind clinical trial in the United States to evaluate adult mesenchymal stem cells (MSC) as a treatment for lupus. The phase II trial will enroll 81 individuals with lupus whose disease is not responding to current therapies. This study marks a bold step forward in lupus research and could diminish the long-term effects of lupus, help lower medication dosage, stop damage to vital organs, and save lives.

Project Title: A Phase II Sequential Dose Escalation Study Evaluating the Safety and Feasibility of Allogenic Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Adults with Treatment Refractory Lupus

Principal Investigators:
PI Gary S. Gilkeson, MD, Medical University of South Carolina
Co-PI, Diane Kamen, MD, Medical University of South Carolina

Learn more

The LFA CDAI initiative is a collaboration among multiple companies to improve lupus clinical trials. Since its inception in 2009, LFA CDAI has published important findings identifying trends and new insights to improve lupus clinical trials. The current LFA CDAI analysis project builds upon this work.

Project Title: An Integrated Analysis of Data from Placebo Group’s Participation in Multi-Center Clinical Trials for Lupus

Principal Investigator: Mimi Kim, ScD, Albert Einstein College of Medicine

More info

The goal of the ALPHA Project is to bring together international lupus experts to develop and implement strategies to address the critical barriers toward improving outcomes in lupus. Through this Project, the international lupus community has reached the first-ever agreement on the barriers to lupus research, drug development, care and access. In January, 2020, A global advisory panel of lupus medical experts and people living with the disease met in Washington, DC to set bold new priorities in lupus drug development, clinical care and access to care.  The Global Advisory Committee is now developing specific strategies to implement that will address the identified priorities on a global scale.

More Information

The Lupus Foundation of America is providing a three-year grant supporting the IMPACT study (IMprove Pregnancy in APS with Certolizumab Therapy), the first trial of a biologic therapy to prevent adverse pregnancy outcomes in high-risk pregnancies in patients with antiphospholipid syndrome (APS) with or without systemic lupus erythematosus (SLE). The lead investigator of the study is Jane Salmon, MD, Collette Kean Research Professor at Hospital for Special Surgery.

Learn More

In 2006, we established the Michael Jon Barlin Pediatric Research Program with the generous support of the Wallace H. Coulter Foundation, in memory of Michael Jon Barlin, who passed away at the age of 24 following a long battle with lupus. With those funds, we became the first and only lupus organization in the United States with a dedicated childhood lupus research agenda. Through this program, we provide funding to facilitate childhood lupus research in areas where there is the greatest need, including kidney disease, quality of life, and neuropsychiatric disease.

Our Michael Jon Barlin Pediatric Lupus Research Program also is supporting a project led by Kathleen Sullivan, MD, MPH, The Children’s Hospital of Philadelphia. Dr. Sullivan is researching HER2, a gene that can play a role in the development of breast cancer and investigating whether it can anticipate flares in children with lupus. Results of this research may lead to real-time evaluation of disease activity.

Project Title: Urinary HER2 as a Biomarker for Lupus Nephritis
Principal Investigator: Kathleen Sullivan, MD, MPH, The Children’s Hospital of Philadelphia

More info

The Gary S. Gilkeson Career Development Award (CDA) provides funding to rheumatology, nephrology, and dermatology fellows who are interested in the most critical areas of lupus research.The CDA aims to reduce the future shortage of lupus researchers by supporting these fellows at a critical and challenging time in their careers – when they must make difficult decisions about their future paths. If we don’t support scientists in the lupus research field, we won’t have the knowledge, studies and advances needed to care for individuals living with this complex disease.

Andrea Fava, MD
Johns Hopkins University School of Medicine
Mentor: Michelle Petri, MD MPH
Title of Project: Defining the role of immature neutrophil populations and IL-16 in lupus nephritis: a spatially resolved multiomics approach

Irene Chernova, MD PhD
Yale University
Mentor: Joseph Craft, MD
Title of Project: The Role of the Ion Microenvironment on B cell Survival and Function in SLE

Carolina Munoz Grajales MD PhD
Toronto Western Hospital
Mentor: Zahi Touma, MD
Title of Project: Elucidating the Risk Factors and Trajectories of Cognitive Impairment in Systemic Lupus Erythematosus

Jordan Roberts, MD
Boston Children’s Hospital
Mentor: Mary Beth Son, MD
Title of Project: Assessing the Impact of Immunosuppressants on Infections in Pediatric Lupus

Ellen Cody, MD
Cincinnati Children's Hospital Medical Center
Mentor: Hermine I. Brunner, M.D. M.Sc. M.B.A
Title of Project: Assessing Performance of Urinary Biomarkers, Renal Activity Index for Lupus (RAIL)

Dominique Kinnett-Hopkins, PhD
University of Michigan, School of Kinesiology
Mentor: Rosalind Ramsey-Goldman, MD, DrPH
Title of Project: A Progressive Home-based Exercise Intervention for Persons with Systemic Lupus Erythematosus

Nicholas Li, MD, PhD
The Ohio State University
Mentor: Brad H. Rovin, MD, FACP, FASN
Title of Project: Characterization of urine complement proteins as biomarkers of lupus nephritis activity

Laura Whittall, MD
University Health Network (Toronto)
Mentor: Murray Urowitz, MD, FRCPC
Title of Project: Interferon alfa as a Biomarker to Predict Lupus Nephritis Response to Treatment

Emily Littlejohn, DO, MPH
Cleveland Clinic
Mentors: Emily Somers, Ph.D, ScM & Jinoos Yazdany, MD, MPH
Study: Longitudinal Antinuclear Antibodies titers from pre-clinical to clinical SLE

Emily Smitherman, MD
University of Alabama at Birmingham
Mentor: Aimee Hersh, MD, MS
Study: Evaluating Disease Activity Outcomes in Childhood-Onset Systemic Lupus Erythematosus

May Choi, MD, FRCPC
University of Calgary
Mentor: Karen Costenbader, MD, MPH
Study: LEAAPPS: Longitudinal Examination of ANA Associations, Prevalence, and Performance in SLE

Erik Anderson, MD
Feinstein Institute for Medical Research
Mentor: Meggan Mackay, MD, MS
Study: Tryptophan Pathway Activation by Interferon-alpha: Impact on Mood and Cognition in SLE

Read more

Joyce Chang, MD
Children’s Hospital of Philadelphia
Mentors: Andrea M. Knight, Pamela F. Weiss
Study: Attenuated Nocturnal Blood Pressure Dipping and Subclinical Atherosclerosis in Child-Onset Lupus

Paul Hoover, MD
Brigham & Women’s Hospital
Study: Dissecting the Role of Myeloid Cells in Lupus Nephritis 

The Gina M. Finzi Memorial Student Summer Fellowship Program is designed to cultivate a life-long interest in lupus research in young scientists and build the next generation of researchers. The fellowship has supported nearly 200 students who have gone on to further success in the fight against lupus, including producing several publications in peer-reviewed journals.

Kristen Bricker
Penn State University College of Medicine
Study Title: miR-21 Regulation of Autoimmune Responses and Lupus Nephritis Development
Mentor: Zia Rahman, MD, PhD Penn State University, Associate Professor of Microbiology and Immunology

Seerat Chawla
University of Toronto
Study Title: Trajectories of Depressive Symptoms in Systemic Lupus Erythematous Over Time
Mentor: Zahi Touma, MD, Ph.D Assistant Professor of Medicine with the University of Toronto, Clinician-Scientist, Staff Rheumatologist with the University Health Network/Mount Sinai Hospital, adjunct scientist with the Institute for Work and Health and LFA MSAC member

Claudia Lovell
School of Medicine at the University of Pennsylvania
Study Title: Defining X Chromosome Inactivation Maintenance and Escape in Age-Associated B Cells
Mentor: Montserrat Anguera, Ph.D. Associate Professor, Department of Biomedical Sciences, University of Pennsylvania School of Veterinary Medicine

Farnoosh Naderinabi
University of Western Ontario
Study Title: Interferon Alfa as a Biomarker to Predict Lupus Nephritis Response to Treatment
Mentor: Murray B. Urowitz, MD, FRCPC, Professor of Medicine at the University of Toronto and Director of the Centre for Prognosis Studies in the Rheumatic Diseases and the Lupus Clinic at the Toronto Western Hospital

Tiffany Taylor
University of California, San Francisco and the University of California, Berkeley
Study Title: Causes of Death Among Minority Populations with Systemic Lupus Erythematosus
Mentor: Jinoos Yazdany, MD, MPH, Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital and the Alice Betts Endowed Professor of Medicine at the University of California San Francisco

Megan Zhao
Perelman School of Medicine at the University of Pennsylvania
Study Title: Assessing the Management of Atherosclerotic Cardiovascular Disease (ASCVD) Risk Factors in Cutaneous Lupus Erythematosus (CLE) Patients
Mentor: Victoria P. Werth, M.D, Chief of Dermatology, Philadelphia V.A. Hospital, Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran’s Administration Medical Center, Professor of Medicine

Zarina Brune
Feinstein Institutes for Medical Research
Study Title: A novel role for IRF5 in CD4+ T cell metabolism drives autoimmunity
Mentor: Betsy Barnes, PhD Investigator Head, Laboratory of Autoimmune and Cancer Research Professor, Departments of Molecular Medicine and Pediatrics

Meera Dhodapkar
Yale School of Medicine
Study Title: Reactivity of VH4-34 IgG Autoantibodies to Commensal Bacteria in Systemic Lupus Erythematosus
Mentor: Eric Meffre, Ph.D., Associate Professor of Immunology and Medicine

Sayra Garcia
Albert Einstein College of Medicine
Study Title: Investigating the Role of Lipocalin-2 in Neuropsychiatric SLE
Mentor: Chaim Putterman, MD, MBA, Professor in the Departments of Medicine and Microbiology & Immunology

Jennifer He
University Health Network (Toronto)
Study Title: Improving the assessment of cognitive function in patients with systemic lupus erythematosus: Insight into intraindividual variability across neuropsychological tests and its association with cognitive impairment
Mentor: Zahi Touma, MD, PhD, FACP, FACR Assistant Professor of Medicine, Department of Medicine, University of Toronto

Jessica Jones
Cleveland Clinic Lerner Research Institute
Study Title: Investigation of the differentiation of male and female derived stem cells to pro-inflammatory and anti-inflammatory cells in a chimeric lupus mouse model
Mentor: Trine N. Jorgensen, Associate Director of Research, Cleveland Clinic Lerner College of Medicine at CWRU

Olivia Solomon
University of California, Berkeley
Study Title: Genetic ancestry impacts on differential outcomes of systemic lupus erythematosus
Mentor: Lindsey A. Criswell, MD, MPH, DSc Professor of Medicine and Orofacial Sciences Chief, Division of Rheumatology Jean S. Engleman Distinguished Professor in Rheumatology

Philip Carlucci
New York University School of Medicine
Study Title: The natural killer cell ligand polymorphism HLA-C Asn80Lys and lupus nephritis.
Mentor: Robert Clancy, Ph.D., Professor, New York School of Medicine

Lin Chen
Brigham and Women’s Hospital
Study Title: Ptprz: Impact on Tubules and Macrophage Mediated Lupus
Mentor: Vicki Rubin Kelley, Ph.D Professor of Medicine, Harvard Medical School

Erica Crosley
Emory School of Medicine
Study Title: Understanding Latino Lupus Patients’ Education Needs via Mixed-Methods Analysis of the Spanish-speaking Facebook Page “Hablemos de Lupus” (“Let’s talk about Lupus”)
Mentor: Christina Drenkard, MD., Ph.D., Associate Professor of Medicine and Epidemiology, Division of Rheumatology, Emory School of Medicine

Erica Moore
Albert Einstein College of Medicine
Study Title: The Pathogenic Role of T Cells in Neuropsychiatric Systemic Lupus Erythematosus
Mentor: Chaim Putterman, MD, Chief and Program Director, Division of Rheumatology, Professor of Medicine and Microbiology & Immunology, Albert Einstein College of Medicine

Kathryn Wierenga
Michigan State University
Study Title: Unraveling How Omega-3 Fatty Acids Suppress Lupus Flaring
Mentor: James Pestka, Ph.D., Professor, Michigan State University

Thomas Winans
SUNY Upstate Medical University
Study Title: The Effects of Rab4A Q72L Knock-In Mutation on Interferons I/II Receptors, Behavior and Brain Metabolome in a Mouse Model
Mentor: Andras Perl, M.D. Ph.D., SUNY Distinguished Professor, Departments of Medicine, Microbiology, and Immunology, Biochemistry and Molecular Biology, Chief, Division of Rheumatology

Marilyn Allen
University of Maryland, Baltimore County
Study Title: Nanoparticle Encapsulated Antimalarial Drugs for Improved Lupus Nephritis Treatment
Mentor: Gregory L. Szeto, PhD

Rachel Nelson
Yale School of Medicine
Study Title: Modulation of Antiphospholipid Antibody-Induced Trophoblast Inflammatory Response by Infectious Components
Mentor: Vikki M. Abrahams, PhD

Jennifer Ra
Washington University School of Medicine
Study Title: Virtual Support: The Key to Bringing Social Support into the Home for Patients with SLE 
Mentor:  Alfred H.J. Kim, MD, PhD

Alanna Hirz
The University of California
Study Title: Measuring Resilience as a Key Psychosocial Indicator for Women with Systemic Lupus Erythematosus 
Mentor: Perry Nicassio, PhD

Mitra Moazzami
University Health Network/University of Toronto
Study Title: Validity and Reliability of Patient-Reported Outcomes Measurement Information System (PROMIS) in Systemic Lupus Erythematosus 
Mentor: Zahi Touma, MD, PhD

Jagan Sivakumaran
University Health Network/University of Toronto
Study Title: Assessment of the QRISK3, SLE Cardiovascular Risk Equation, Modified Framingham and Framingham Risk Calculators as Predictors for Development of Atherosclerotic Cardiovascular Disease in Patients with Systemic Lupus Erythematosus
Mentor: Zahi Touma, MD, PhD

The Lupus Foundation of America partners with Lupus Canada to fund innovative lupus research through the Lupus Canada Catalyst Award. The award supports research projects that have the potential to significantly advance the field or impact the lives of people with lupus. 

Researchers: Dr. Zahi Touma & Dr. Michelle Barraclough

University Health Network

A pilot study examining the relationship between cognitive dysfunction and cognitive fatigue in SLE using structural and functional MRIs of the brain and focusing on the underlying mechanism.

Read the project summary

Researchers: Dr. Leslie Skeith & Dr. Megan Barber

Mentor: Ann Clarke

University of Calgary 

A prospective cohort study evaluating complement and platelet activation among lupus patients with antiphospholipid syndrome.

Read the project summary